Tag Archives: Colorectal

Array’s colorectal cancer data shows why Pfizer splashed out $11B for the biotech

One key incentive for Pfizer paying $ 11 billion for Array BioPharma was the positive early readouts from its triplet therapy for colorectal cancer. Now, the biotech has shown exactly how attractive that data are. A combination of Array’s BRAF inhibitor Braftovi, its MEK inhibitor Mektovi and the anti-EGFR drug Erbitux significantly extended lives of previously-treated patients… Read More »

Can Daily Consumption of Meat Increase Colorectal Cancer Risk?

For some time, cancer organizations have recommended diets that limit processed and red meat because consumption of these foods is linked to cancer. Now, a new study published in the International Journal of Epidemiology reveals that even folks who follow guidelines may have a slightly increased risk of developing colorectal cancer, reports Cancer Research UK.… Read More »